MGLN Magellan Health, Inc.
Magellan Health, Inc. engages in the healthcare management business. It operates through the following segments: Healthcare, Pharmacy Management and Corporate. The Healthcare segment comprises of the Commercial and Government reporting units. The Pharmacy Management segment offers products and solutions that provide clinical and financial management of pharmaceuticals paid under both the medical and the pharmacy benefit.The Corporate segment covers amounts not allocated to the Healthcare and Pharmacy Management segments. The company was founded in 1969 and is headquartered in Phoenix, AZ.
Company profile
Ticker
MGLN
Exchange
Website
CEO
Kenneth J. Fasola
Employees
Incorporated in
Location
Fiscal year end
Sector
Industry (SEC)
Former names
Charter Medical Corp, Magellan Health Services Inc
SEC CIK
Corporate docs
IRS number
581076937
MGLN stock data
()
Calendar
1 Nov 19
14 Dec 19
31 Dec 19
News
Company financial data Financial data
| Quarter (USD) | Sep 19 | Jun 19 | Mar 19 | Dec 18 | |
|---|---|---|---|---|---|
| Revenue | 1.83B | 1.79B | 1.74B | 1.84B | |
| Net income | 21.27M | 13.61M | 431K | -27.97M | |
| Diluted EPS | 0.86 | 0.56 | 0.02 | -1.16 | |
| Net profit margin | 1.16% | 0.76% | 0.02% | -1.52% | |
| Net change in cash | 13.2M | -9.3M | 4.8M | -12.2M | |
| Cash on hand | 17.5M | 4.3M | 13.6M | 8.8M | |
| Cost of revenue | 482.28M | 461.19M | 489.79M | 593.79M |
| Annual (USD) | Dec 18 | Dec 17 | Dec 16 | Dec 15 | |
|---|---|---|---|---|---|
| Revenue | 7.31B | 5.84B | 4.84B | 4.6B | |
| Net income | 24.18M | 110.21M | 77.88M | 31.41M | |
| Diluted EPS | 0.97 | 4.51 | 3.22 | 1.21 | |
| Net profit margin | 0.33% | 1.89% | 1.61% | 0.68% | |
| Net change in cash | -105.9M | -12.3M | -33.2M | 44.2M | |
| Cash on hand | 8.8M | 114.7M | 127M | 160.2M | |
| Cost of revenue | 2.28B | 2.21B | 1.82B | 1.32B |
Financial data from company earnings reports
Content analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
announced, appointment, attached, Barry, compensatory, document, embedded, Fasola, incorporated, interactive, Kenneth, NaN, reference, Shulman, Smith, step, Steven, voluntary, XBRL
Removed:
April
Financial reports
10-Q
2019 Q3
Quarterly report
1 Nov 19
10-Q
2019 Q2
Quarterly report
30 Jul 19
10-Q
2019 Q1
Quarterly report
2 May 19
10-K
2018 FY
Annual report
28 Feb 19
10-Q
2018 Q3
Quarterly report
7 Nov 18
10-Q
2018 Q2
Quarterly report
27 Jul 18
10-Q
2018 Q1
Quarterly report
26 Apr 18
10-K
2017 FY
Annual report
1 Mar 18
10-Q
2017 Q3
Quarterly report
1 Nov 17
10-Q
2017 Q2
Quarterly report
28 Jul 17
Current reports
8-K
Magellan Health Board of Directors Appoints James Murray as President and Chief Operating Officer of Magellan Health
5 Dec 19
8-K
Departure of Directors or Certain Officers
12 Nov 19
8-K
Other Events
8 Nov 19
8-K
Magellan Health Reports Third Quarter 2019 Financial Results
1 Nov 19
8-K
Magellan Health Board of Directors Appoints Kenneth J. Fasola as Chief Executive Officer
31 Oct 19
8-K
Departure of Directors or Certain Officers
28 Aug 19
8-K
Magellan Health Reports Second Quarter 2019 Financial Results and Confirms Full Year Guidance
30 Jul 19
8-K
Submission of Matters to a Vote of Security Holders
21 Jun 19
8-K
Magellan Health Reports First Quarter 2019 Financial Results
2 May 19
8-K
Departure of Directors or Certain Officers
23 Apr 19
Registration and prospectus
S-8
Registration of securities for employees
12 Jun 18
424B2
Prospectus for primary offering
18 Sep 17
424B2
Prospectus for primary offering
15 Sep 17
FWP
Free writing prospectus
15 Sep 17
S-3ASR
Automatic shelf registration
31 Aug 17
S-8
Registration of securities for employees
29 Jul 16
S-8
Registration of securities for employees
3 Jun 14
S-8
Registration of securities for employees
18 May 11
S-8
Registration of securities for employees
18 May 11
S-8
Registration of securities for employees
21 May 08
Proxies
DEF 14A
Definitive proxy
29 Apr 19
DEFA14A
Additional proxy soliciting materials
22 Feb 19
DFAN14A
Additional proxy materials by non-management
22 Feb 19
DEF 14A
Definitive proxy
9 Apr 18
DEF 14A
Definitive proxy
12 Apr 17
PRE 14A
Preliminary proxy
21 Mar 17
DEF 14A
Definitive proxy
8 Apr 16
DEFA14A
Additional proxy soliciting materials
29 Apr 15
DEFA14A
Additional proxy soliciting materials
17 Apr 15
DEF 14A
Definitive proxy
10 Apr 15
Other
UPLOAD
Letter from SEC
30 May 17
CORRESP
Correspondence with SEC
19 May 17
UPLOAD
Letter from SEC
10 May 17
UPLOAD
Letter from SEC
1 Sep 16
CORRESP
Correspondence with SEC
29 Aug 16
CT ORDER
Confidential treatment order
23 Aug 16
UPLOAD
Letter from SEC
2 Aug 16
UPLOAD
Letter from SEC
10 Sep 15
CORRESP
Correspondence with SEC
11 Aug 15
UPLOAD
Letter from SEC
31 Jul 15
Ownership
SC 13D/A
Magellan Health Inc
29 Mar 19
SC 13D/A
Magellan Health Inc
22 Feb 19
SC 13G/A
Magellan Health Inc
11 Feb 19
SC 13G/A
Magellan Health Inc
8 Feb 19
SC 13G/A
Magellan Health Inc
31 Jan 19
SC 13D
Magellan Health Inc
13 Dec 18
SC 13G/A
Magellan Health Inc
10 Jul 18
SC 13G/A
Magellan Health Inc
9 Feb 18
SC 13G/A
Magellan Health Inc
9 Feb 18
SC 13G/A
Magellan Health Inc
19 Jan 18